ACCSYS TECHNOLOGIES PLC

AGM Information • Dec 15, 2025

RNS Number : 7005A Accsys Technologies PLC 24 September 2025

AIM: AXS

Euronext Amsterdam: AXS

24 September 2025

Accsys Technologies PLC

("Accsys", the "Group" or "the Company")

Results of AGM

Accsys, the world's leading supplier of premium, high performance and sustainable wood building materials, today confirms that all the resolutions put to the Annual General Meeting ("AGM") held on Wednesday 24 September 2025 were duly passed. All resolutions were decided on a poll. Resolutions 1 to 11 were passed as ordinary resolutions and resolutions 12 to 15 were passed as special resolutions. The voting results are set out below.

Resolution	For		Against		of issued share capital voted	Votes withheld
	Number	%	Number	%	%	Number
Ordinary Resolutions
1: To receive the audited financial statements of the Company for the financial year ended 31 March 2025.	125,946,210	99.97	39,337	0.03	51.92	15,109
2: To approve the Directors' Remuneration Report (excluding the Remuneration Policy) for the financial year ended 31 March 2025.	125,510,764	99.62	479,837	0.38	51.92	10,055
3: To re-elect Trudy Schoolenberg as a director.	125,824,802	99.87	163,990	0.13	51.92	11,864
4. To re-elect Louis Eperjesi as a director.	125,793,475	99.85	190,317	0.15	51.92	16,864
5: To re-elect Roland Waibel as a director.	125,793,475	99.85	190,317	0.15	51.92	16,864
6: To re-elect Edwin Bouwman as a director.	125,733,245	99.80	250,547	0.20	51.92	16,864
7: To re-elect Jelena Arsic van Os as a director.	125,814,549	99.86	174,243	0.14	51.92	11,864
8: To elect Sameet Vohra as a director.	125,509,923	99.62	474,772	0.38	51.92	15,961
9: To re-appoint PricewaterhouseCoopers LLP as auditors.	125,904,560	99.94	78,189	0.06	51.92	17,907
10: To authorise the directors to determine the remuneration of the auditor.	125,577,815	99.90	123,907	0.10	51.92	298,934
11: To authorise the directors to allot shares.	125,458,153	99.58	530,766	0.42	51.92	11,737
Special Resolutions
12: To authorise the Directors to disapply statutory pre-emption rights in respect of 10% of the Company's issued share capital.	125,441,250	99.57	546,090	0.43	51.92	13,316
13: To authorise the Directors to disapply pre emption rights for purposes of acquisitions or capital investments over an additional 10% of the Company's issued share capital.	125,477,748	99.59	512,592	0.41	51.92	10,316
14: To authorise the Company to purchase own shares.	125,804,525	99.85	187,394	0.15	51.92	8,737

15: To authorise a general meeting of the Company (other than an annual general meeting) to be called on not less than 14 clear days' notice	125,909,685	99.94	78,136	0.06	51.92	12,835
-------------------------------------------------------------------------------------------------------------------------------------------------------------	-------------	-------	--------	------	-------	--------

• 1. Any proxy arrangement which gave discretion to the Chairman has been included in the "for" totals.
• 1. A "Vote withheld" is not a vote in law and is not counted in the calculation of the percentage of shares voted "For" or "Against" any resolution.
• 1. The issued share capital ("ISC") at 6:00 p.m. on 22 September 2025 was 242,694,212Ordinary shares of €0.05 each with no shares held in treasury.

Enquiries:

Accsys Investor Relations ir@accsysplc.com

Panmure Liberum (London) - NOMAD and Broker

Nicholas How (NOMAD), Will King +44 (0) 20 3100 2000

ABN Amro (Amsterdam) - Broker

Richard van Etten, Dennis van Helmond +31 (0) 20 344 2000

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

RAGPKQBDABKDDCB